FUROSEMIDE S.A.L.F. 250mg/25ml solution for infusion or 20mg/2ml solution for injection

FUROSEMIDE S.A.L.F.  250mg/25ml solution for infusion or 20mg/2ml solution for injection
Product Description

Pharmacotherapeutic group: Diuretics with a

major diuretic action.

Furosemide, a synthesis saluretic agent, causes

an increase in water and sodium elimination,

even in cases in which the glomerular filtration

is very limited.

The natriuretic effect is dose-dependent,

therefore, furosemide allows to obtain a guided

diuresis; instead, the urinary excretion of potassium

is significantly limited. As a result, the

sodium-potassium ratio is extremely favorable.

The diuretic effect following an oral administration

begins within the first hour and lasts 4-6

hours; by intravenous administration the effect

occurs within few minutes and lasts about 2

hours, while by intramuscular administration

the effect occurs a few minutes later, but the

duration of the action is longer.

PACKAGING:

Furosemide S.A.L.F. 250 mg/25 ml

solution for injection - 5 x 25 ml

vials A.I.C. 030671046 (Italian MA)

Furosemide S.A.L.F. 20 mg/2 ml

solution for injection - 5 x 2 ml

ampoules A.I.C. 030671010 (Italian MA)

S.A.L.F SpA

  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

S.A.L.F SpA

  • IT
  • 2015
    On CPHI since
  • 5
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from S.A.L.F SpA (4)

  • METOCLOPRAMIDE S.A.L.F. 10mg/2ml

    Product METOCLOPRAMIDE S.A.L.F. 10mg/2ml

    La metoclopramide stimola e coordina la motilità del tratto superiore dell’apparato gastroenterico, senza modificare la secrezione gastrica, pancreatica e biliare.Il suo meccanismo d’azione è complesso, essendo il farmaco antagonista competitivo dei recettori D1 e D2 (dopamina) e dei recettori 5-HT3 (s...
  • DOPAMINE S.A.L.F.

    Product DOPAMINE S.A.L.F.

    Dopamine acts as an agonist on specific dopamine receptors and on alpha and beta adrenergic receptors. It decreases peripheral resistance and causes mesenteric and renal vasodilation. It increases renal blood flow, glomerular filtration and urinary flow. ...
  • SERVATOR B SALF

    Product SERVATOR B SALF


    The solution is intended for perfusion and

    hypothermic preservation of kidney, liver and

    pancreas.

    The solution kept bewween at 2° and 6° C (36°

    -43° F) is used to spray the isolated organ

    immediately before or immedi...
  • BLU PATENT V 2.5% S.A.L.F.  (medical device)

    Product BLU PATENT V 2.5% S.A.L.F. (medical device)


    Patent Blue V is a vital dye suitable for the marking

    of the sentinel lymph node in breast cancer

    and the intraoperative research of the sentinel

    lymph node in patients with colon cancer. It is

    also used in preoperative lymphoscintigraph...

S.A.L.F SpA resources (1)